Donald Notman, Chief Financial Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 6,212 shares at $4.86 ($30K) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Scheduled sale ($30k) by Chief Financial Officer.
Something here stands out, but not much.
| Filing → |
| OCUL | SELL | 2026-02-04 | $101K | — | Filing → |
| OCUL | SELL | 2025-09-04 | $13K | — | Filing → |
| OCUL | SELL | 2025-02-04 | $223K | — | Filing → |